Sinopharm Guangzhou completed the first sale of the new oral drug Monoprevir
Cases & Data

Sinopharm Guangzhou completed the first sale of the new oral drug Monoprevir

Covid-19 News
Read Time:8 Second

On January 13, 2023, Sinopharm Guangzhou completed the first national sale of the new oral drug “Monoprevir”, marking the official launch of the drug into clinical use.

About Post Author

Covid-19 News

[email protected]
https://covid-19.news
Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
0 0

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
(Add your review)

Leave a Reply

Your email address will not be published. Required fields are marked *

Beijing CDC experts explain the difference between vaccines for inhalation and nasal spray vaccines Previous post Beijing CDC experts explain the difference between vaccines for inhalation and nasal spray vaccines
Pfizer bivalent vaccine linked to increased risk of stroke in older adults? U.S. Health Authorities: Investigation underway, no need to change vaccination guidelines at this time Next post Pfizer bivalent vaccine linked to increased risk of stroke in older adults? U.S. Health Authorities: Investigation underway, no need to change vaccination guidelines at this time

More Stories